Jens‐Otto Andreas - Concepedia

Author

Jens‐Otto Andreas

UCB Pharma (Germany)

Also Known As

J O Andreas, J. Andreas, J. O. Andreas, J.-O. Andreas, Jens-Otto Andreas, Jens‐Otto Andreas

Publications

545

Citations

H-Index

Concepts

All Affiliations

UCB Pharma (Germany)Essen University Hospital University Medical Center Freiburg Grünenthal Group (Germany)

About

Jens‐Otto Andreas is an author at UCB Pharma (Germany) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	256
2	Public Health	1	1	47
3	Social Sciences	1	1	46
4	Metabolism	1	1	38
5	Neuroscience	1	1	46

Jens‐Otto Andreas

Publications

447

Citations

H-Index

Page 1

	Year	Citations
Steady-State Plasma Concentration Profile of Transdermal Rotigotine: An Integrated Analysis of Three, Open-Label, Randomized, Phase I Multiple Dose Studies Jan‐Peer Elshoff, Marina Braun, Jens‐Otto Andreas, Clinical Therapeutics Pharmaceutical ScienceIntegrated AnalysisMedicineMultiple Dose StudiesTransdermal Rotigotine	2012	108
Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara<sup>®</sup>) and EE/LNG (Microgynon<sup>®</sup>) I. Worret, W. Arp, H. P. Zahradnik, Dermatology	2001	88
Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: Saliva as a surrogate of pharmacokinetics in the central compartment Willi Cawello, Hilmar Bökens, Brunhild Nickel, Epilepsia	2012	52
Efficacy and Safety of the New Antiandrogenic Oral Contraceptive Belara® H. P. Zahradnik, Jens‐Otto Andreas Contraception ContraceptionContraceptive UseContraceptive ImplantsHormonal ContraceptiveSexual And Reproductive Health	1998	47
Differential effects of human ether-a-go-go-related gene (HERG) blocking agents on QT duration variability in conscious dogs Johannes Schneider, Renate Hauser, Jens‐Otto Andreas, European Journal of Pharmacology Veterinary Behavioral MedicineQt Duration VariabilityMedicineHuman Ether-a-go-go-related GeneBehavioral Pharmacology	2005	46
Long-term metabolic effects in patients with urinary diversion Raimund Stein, Johannes Lotz, Jens‐Otto Andreas, World Journal of Urology HemodialysisUrologyRenal FunctionSurgeryMetabolism	1998	38
A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel. Ulrich Winkler, E. Daume, R Sudik, PubMed	1999	22
Lack of Pharmacokinetic Interactions Between Transdermal Rotigotine and Oral Levodopa/Carbidopa Marina Braun, Willi Cawello, Jens‐Otto Andreas, The Journal of Clinical Pharmacology	2009	19
Effect of Lacosamide on the Steady-State Pharmacokinetics of Digoxin: Results from a Phase I, Multiple-Dose, Double-Blind, Randomised, Placebo-Controlled, Crossover Trial Willi Cawello, Christa Mueller-Voessing, Jens‐Otto Andreas Clinical Drug Investigation Crossover TrialPharmacologyPharmacotherapyMedicinePhysiologically-based Pharmacokinetic Modeling	2014	17
A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 μg ethinylestradiol and either 2 mg chlormadinone acetate or 150 μg desogestrel Ulrich Winkler, E. Daume, R Sudik, The European Journal of Contraception & Reproductive Health Care	1999	10

Page 1